Study to Evaluate Immunogenicity

By Deanna SonniAgosto 22, 2019#!31Sab, 04 Dic 2021 00:43:35 +0000+00:003531#31Sab, 04 Dic 2021 00:43:35 +0000+00:00-12+00:003131+00:00x31 04am31am-31Sab, 04 Dic 2021 00:43:35 +0000+00:0012+00:003131+00:00x312021Sab, 04 Dic 2021 00:43:35 +000043124312amsabato=706#!31Sab, 04 Dic 2021 00:43:35 +0000+00:00+00:0012#Dicembre 4th, 2021#!31Sab, 04 Dic 2021 00:43:35 +0000+00:003531#/31Sab, 04 Dic 2021 00:43:35 +0000+00:00-12+00:003131+00:00x31#!31Sab, 04 Dic 2021 00:43:35 +0000+00:00+00:0012#No Comments

CLINICALTRIALS

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals’ Candidate Malaria Vaccine (257049)

https://clinicaltrials.gov/ct2/show/results/NCT01345240?cond=malaria+vaccine&rank=5&view=results

Dona amore

Study to Evaluate Immunogenicity

Previous PostConcluso il progetto Finanziato fondi OPM Valdesi

Next PostDrug-resistant malaria is spreading across Asia

Rispondi